ijms-logo

Journal Browser

Journal Browser

Molecular Advances in Forensic Toxicology: Innovative Approaches in Detection of New Psychoactive Substances

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Toxicology".

Deadline for manuscript submissions: closed (25 February 2026) | Viewed by 10653

Special Issue Editors


E-Mail Website
Guest Editor
Laboratory of Forensic Toxicology, Section of Legal and Forensic Medicine, Social Security and Forensic Toxicology, Department of Biomedicine and Prevention, Faculty of Medicine and Surgery, University of Rome “Tor Vergata”, Via Montpellier 1, 00133 Rome, Italy
Interests: toxicological analysis; new psychoactive substances; forensic toxicology; drug toxicity; drug diversion

E-Mail Website
Guest Editor
Laboratory of Forensic Toxicology, Section of Legal and Forensic Medicine, Social Security and Forensic Toxicology, Department of Biomedicine and Prevention, Faculty of Medicine and Surgery, University of Rome “Tor Vergata”, Via Montpellier 1, 00133 Rome, Italy
Interests: toxicological analysis; forensic toxicology; drug toxicity; new psychoactive substances; method validation

Special Issue Information

Dear Colleagues,

In recent years, the field of forensic toxicology has expanded significantly, meaning that forensic toxicologists face new technical and analytical challenges in determining substances of abuse and their metabolites in biological and non-biological samples.

The introduction of an increasing number of new molecules into the illicit market of new psychoactive substances (NPSs) and an increase in the non-medical use of pharmaceuticals and drugs have made it more difficult to develop fast and sensitive analytical methods for the rapid determination of the molecular structure of parent compounds and their metabolites.

The high risk of consumption of new substances is closely related to the lack of knowledge of their potency and abuse potential, representing a serious public health problem.

Current methodological analyses include chromatographic techniques coupled with mass spectrometry for the molecular identification and quantification of psychotropic substances and high-resolution mass spectrometry (HRMS) approaches, which are used to identify new molecules and study their metabolites.

We would like to invite you to contribute to our Special Issue in International Journal of Molecular Sciences (IJMS), entitled “Molecular Advances in Forensic Toxicology: Innovations Approaches in Detection of New Psychoactive Substances”, which will focus on the importance of the sample preparation, development and implementation of analytical methods for the molecular detection of psychotropic substances in biological and non-biological matrices.

Dr. Roberta Tittarelli
Dr. Giulio Mannocchi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • addiction
  • new psychoactive substances
  • mass spectrometry
  • biological matrices
  • diversion
  • forensic toxicology
  • drug testing

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

20 pages, 1440 KB  
Article
Oral Fluid Concentrations and Pharmacological Effects of Clephedrone and Methylone in Humans
by Lourdes Poyatos, Melani Núñez-Montero, Olga Hladun, Georgina De la Rosa, Soraya Martín, Sebastian Videla, Silvia Martínez-Couselo, Mireia Ventura, Nunzia La Maida, Annagiulia Di Trana, Francesco Paolo Busardò, Marta Torrens, Simona Pichini, Clara Pérez-Mañá, Magí Farré and Esther Papaseit
Int. J. Mol. Sci. 2026, 27(1), 89; https://doi.org/10.3390/ijms27010089 - 21 Dec 2025
Viewed by 1857
Abstract
Synthetic cathinones represent the second most frequently reported group of new psychoactive substances identified annually, according to the United Nations. It remains unknown whether specific derivatives differ in the onset of effects related to absorption kinetics. Clephedrone (4-chloromethcathinone, 4-CMC) has been among the [...] Read more.
Synthetic cathinones represent the second most frequently reported group of new psychoactive substances identified annually, according to the United Nations. It remains unknown whether specific derivatives differ in the onset of effects related to absorption kinetics. Clephedrone (4-chloromethcathinone, 4-CMC) has been among the most frequently seized cathinones in recent years; however, available data on its pharmacology and abuse potential remain scarce. A non-controlled, prospective, observational study was conducted involving eight healthy volunteers (six women) who self-administered a single oral dose of clephedrone (100 or 150 mg). Study variables were assessed at baseline and over a 5-h period following administration, including vital signs and subjective effects. Oral fluid concentrations of clephedrone and cortisol were determined. For comparison, this article also presents previously unpublished data from a pilot study in which 12 healthy male participants received 150 or 200 mg of methylone under comparable conditions to evaluate effects. Results indicated that both clephedrone and methylone produced stimulant-like subjective effects. However, clephedrone exhibited a delayed onset and peak of effects compared with methylone, indicating a clinically relevant pharmacokinetic difference. Both substances were detected in oral fluid, with peak concentrations occurring later following clephedrone administration, consistent with its delayed pharmacodynamic profile. Full article
Show Figures

Figure 1

22 pages, 1875 KB  
Article
Biochemical Identification and Clinical Description of Medetomidine Exposure in People Who Use Fentanyl in Philadelphia, PA
by Phil Durney, Jennifer L. Kahoud, TaReva Warrick-Stone, Maeve Montesi, Meg Carter, Sabrina Butt, Alberto Martinez Mencia, Louisa Omoregie, Monali Shah, Mariah Bloomfield, Nicholas Tomasko, Rebecca Jaffe, Allison Herens, Warren R. Korn, Karen Alexander, Douglas Stickle, Dennis Goodstein, Lara Carson Weinstein and Kory S. London
Int. J. Mol. Sci. 2025, 26(14), 6715; https://doi.org/10.3390/ijms26146715 - 13 Jul 2025
Cited by 10 | Viewed by 3448
Abstract
Medetomidine, a veterinary α2-adrenergic agonist, has recently emerged as an adulterant in the non-medical opioid supply, yet human exposure has remained poorly characterized. We conducted a pragmatic retrospective cohort analysis utilizing chart review and liquid chromatography–tandem mass spectrometry (LC-MS/MS) toxicology testing on available [...] Read more.
Medetomidine, a veterinary α2-adrenergic agonist, has recently emerged as an adulterant in the non-medical opioid supply, yet human exposure has remained poorly characterized. We conducted a pragmatic retrospective cohort analysis utilizing chart review and liquid chromatography–tandem mass spectrometry (LC-MS/MS) toxicology testing on available urine samples from patients presenting to two hospitals in Philadelphia, PA, who fit two clinical phenotypes, intoxication or withdrawal. Samples also underwent glucuronidase pre-treatment to assess impact on the yield of medetomidine and xylazine metabolite detection. Testing identified universal exposure to medetomidine (58/58 samples) via the 3-hydroxy-medetomidine (3-OH-M) metabolite, post glucuronidase treatment and variable xylazine exposure (40/58 samples). Importantly, 32% of medetomidine exposures would have been missed without enzymatic pre-treatment. Patients exhibited two distinct clinical phenotypes: intoxication, characterized primarily by sedation; bradycardia; and often hypotension, and withdrawal, presenting with life-threatening tachycardia; hypertension and often encephalopathy. Notably, clinical phenotype correlated with urinary concentrations of 3-OH-M but not xylazine. These findings underscore the critical need for heightened clinical awareness and need for contemporaneous toxicologic screening mechanisms for medetomidine exposure, emphasizing its distinct clinical presentations and the potential public health implications posed by its widespread adulteration in illicit opioids. Full article
Show Figures

Figure 1

13 pages, 1568 KB  
Article
Development and Validation of a Fast and Sensitive UPLC-MS/MS Method for Ethyl Glucuronide (EtG) in Hair, Application to Real Cases and Comparison with Carbohydrate-Deficient Transferrin (CDT) in Serum
by Leonardo Romani, Giulio Mannocchi, Federico Mineo, Francesca Vernich, Lucrezia Stefani, Luigi Tonino Marsella and Roberta Tittarelli
Int. J. Mol. Sci. 2025, 26(3), 1344; https://doi.org/10.3390/ijms26031344 - 5 Feb 2025
Cited by 2 | Viewed by 4447
Abstract
Alcohol is responsible for an ever-increasing number of deaths worldwide, and many road accidents are caused by irresponsible drinking and driving. The use of biomarkers that can support a diagnosis of alcohol abuse is a very important tool that can improve the prevention [...] Read more.
Alcohol is responsible for an ever-increasing number of deaths worldwide, and many road accidents are caused by irresponsible drinking and driving. The use of biomarkers that can support a diagnosis of alcohol abuse is a very important tool that can improve the prevention of many alcohol-related diseases and serious traffic accidents. The main aim of our study was the full validation of a rapid and simple method by ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) to detect ethyl glucuronide in hair (hEtG). The method was successfully applied to n = 171 real hair samples collected from drivers convicted of driving while impaired by alcohol or drugs. A comparison of hEtG and serum Carbohydrate-Deficient Transferrin percentages (% CDT) was also performed to carefully evaluate the data in relation to the specific detection windows of the two different biomarkers. Most of the drivers with hEtG > 30 pg/mg were males in their thirties. None of the hEtG-positives had a serum % CDT above the cutoff (≥2%). Although some researchers suggest caution until solid data are available on the possible effects of interindividual variability that may influence EtG incorporation and metabolism, hEtG is a very useful biomarker of long-term alcohol exposure that shows greater reliability than traditional blood markers. Full article
Show Figures

Figure 1

Back to TopTop